|
| Exchange Disseminated Time 04/08/2016 16:29:41 | Fortis Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 04, 2016, inter alia, has considered and approved the following:
1. Re-appointment of Mr. Sunil Godhwani and Mr. Ravi Umesh Mehrotra, Directors of the Company, who are liable to retire by rotation at the ensuing Annual General Meeting and being eligible offers themselves for re-appointment.
2. Shifting of Registered office from NCT of Delhi to State of Punjab and Notice of Postal Ballot along with Appointment of scrutinizer for the same.
3. enabling fund raising option upto Rs.5000 Crore including but not limited to qualified institutions placement (QIP), Foreign Currency Convertible Bond (FCCB), convertible securities or any other method and to recommend the same to the shareholders for their approval at the ensuing Annual General Meeting of the Company.
4. In-principle approval to demerge its diagnostic business which includes operations in SRL Limited, and in this regard the Board has formed a Restructuring Committee to detail the nuances of the demerger structure, including valuation, share entitlement ratio and other incidental matters and to present the same before the Board on August 19, 2016 for final approval.
The meeting concluded at 4:15 p.m. |
|
|